Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science

J. Compston, D. M. Reid, J. Boisdron, M. -L. Brandi, N. Burlet, D. Cahall, P. D. Delmas, W. Dere, J. -P. Devogelaer, L. A. Fitzpatrick, B. Flamion, N. Goel, S. Korte, A. Laslop, B. Mitlak, S. Ormarsdottir, J. Ringe, R. Rizzoli, Y. Tsouderos, T. Van StaaJ. -Y. Reginster

Research output: Contribution to journalArticle

19 Citations (Scopus)
Original languageEnglish
Pages (from-to)1247-1250
Number of pages4
JournalOsteoporosis International
Volume19
Issue number9
Early online date5 Jul 2008
DOIs
Publication statusPublished - Sep 2008

Keywords

  • bone mineral density
  • bridging study
  • glucocorticoid-induced osteoporosis
  • men
  • phase III studies
  • postmenopausal women
  • corticosteroid-induced osteoperosis
  • oral corticosteroids
  • fracture risk
  • bone loss
  • metaanalysis
  • risedronate
  • alendronate
  • therapy

Cite this

Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis : an update from the Group for the Respect of Ethics and Excellence in Science. / Compston, J.; Reid, D. M.; Boisdron, J.; Brandi, M. -L.; Burlet, N.; Cahall, D.; Delmas, P. D.; Dere, W.; Devogelaer, J. -P.; Fitzpatrick, L. A.; Flamion, B.; Goel, N.; Korte, S.; Laslop, A.; Mitlak, B.; Ormarsdottir, S.; Ringe, J.; Rizzoli, R.; Tsouderos, Y.; Van Staa, T.; Reginster, J. -Y.

In: Osteoporosis International, Vol. 19, No. 9, 09.2008, p. 1247-1250.

Research output: Contribution to journalArticle

Compston, J, Reid, DM, Boisdron, J, Brandi, M-L, Burlet, N, Cahall, D, Delmas, PD, Dere, W, Devogelaer, J-P, Fitzpatrick, LA, Flamion, B, Goel, N, Korte, S, Laslop, A, Mitlak, B, Ormarsdottir, S, Ringe, J, Rizzoli, R, Tsouderos, Y, Van Staa, T & Reginster, J-Y 2008, 'Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science', Osteoporosis International, vol. 19, no. 9, pp. 1247-1250. https://doi.org/10.1007/s00198-008-0670-7
Compston, J. ; Reid, D. M. ; Boisdron, J. ; Brandi, M. -L. ; Burlet, N. ; Cahall, D. ; Delmas, P. D. ; Dere, W. ; Devogelaer, J. -P. ; Fitzpatrick, L. A. ; Flamion, B. ; Goel, N. ; Korte, S. ; Laslop, A. ; Mitlak, B. ; Ormarsdottir, S. ; Ringe, J. ; Rizzoli, R. ; Tsouderos, Y. ; Van Staa, T. ; Reginster, J. -Y. / Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis : an update from the Group for the Respect of Ethics and Excellence in Science. In: Osteoporosis International. 2008 ; Vol. 19, No. 9. pp. 1247-1250.
@article{664f17a95de74bc68c18a1062a853367,
title = "Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science",
keywords = "bone mineral density, bridging study, glucocorticoid-induced osteoporosis, men, phase III studies, postmenopausal women, corticosteroid-induced osteoperosis, oral corticosteroids, fracture risk, bone loss, metaanalysis, risedronate, alendronate, therapy",
author = "J. Compston and Reid, {D. M.} and J. Boisdron and Brandi, {M. -L.} and N. Burlet and D. Cahall and Delmas, {P. D.} and W. Dere and Devogelaer, {J. -P.} and Fitzpatrick, {L. A.} and B. Flamion and N. Goel and S. Korte and A. Laslop and B. Mitlak and S. Ormarsdottir and J. Ringe and R. Rizzoli and Y. Tsouderos and {Van Staa}, T. and Reginster, {J. -Y.}",
year = "2008",
month = "9",
doi = "10.1007/s00198-008-0670-7",
language = "English",
volume = "19",
pages = "1247--1250",
journal = "Osteoporosis International",
issn = "0937-941X",
publisher = "SPRINGER-VERLAG LONDON LTD",
number = "9",

}

TY - JOUR

T1 - Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis

T2 - an update from the Group for the Respect of Ethics and Excellence in Science

AU - Compston, J.

AU - Reid, D. M.

AU - Boisdron, J.

AU - Brandi, M. -L.

AU - Burlet, N.

AU - Cahall, D.

AU - Delmas, P. D.

AU - Dere, W.

AU - Devogelaer, J. -P.

AU - Fitzpatrick, L. A.

AU - Flamion, B.

AU - Goel, N.

AU - Korte, S.

AU - Laslop, A.

AU - Mitlak, B.

AU - Ormarsdottir, S.

AU - Ringe, J.

AU - Rizzoli, R.

AU - Tsouderos, Y.

AU - Van Staa, T.

AU - Reginster, J. -Y.

PY - 2008/9

Y1 - 2008/9

KW - bone mineral density

KW - bridging study

KW - glucocorticoid-induced osteoporosis

KW - men

KW - phase III studies

KW - postmenopausal women

KW - corticosteroid-induced osteoperosis

KW - oral corticosteroids

KW - fracture risk

KW - bone loss

KW - metaanalysis

KW - risedronate

KW - alendronate

KW - therapy

U2 - 10.1007/s00198-008-0670-7

DO - 10.1007/s00198-008-0670-7

M3 - Article

VL - 19

SP - 1247

EP - 1250

JO - Osteoporosis International

JF - Osteoporosis International

SN - 0937-941X

IS - 9

ER -